| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |